Tempus is engaged in an escalating series of lawsuits with competitor Guardant Health, which alleges patent infringement on its core xF and xM liquid biopsy product lines. This creates significant legal costs, management distraction, and potential risk of injunctive relief or damages that could impact revenue and market position.
Filing excerpt
On June 11, 2024, Guardant Health Inc., or Guardant, filed a complaint against us in the U.S. District Court for the District of Delaware. The complaint alleges that the Tempus xF, Tempus xF+, Tempus xM Monitor and Tempus xM MRD products use liquid biopsy technology that infringes five Guardant U.S. patents.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Competitors
Regions named
sec-10qlitigationMaterialGet every 10-Q signal for Tempus AI and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Tempus AI this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/e4d56cc8-c580-43cc-ad58-5f43af4032b5 returns this record as JSON. POST /v1/companies/enrich returns every signal for tempus.com.
{
"signal_id": "e4d56cc8-c580-43cc-ad58-5f43af4032b5",
"signal_type": "sec-10q",
"signal_subtype": "litigationMaterial",
"detected_at": "2026-05-12T09:24:56.656+00:00",
"company": {
"name": "Tempus AI",
"domain": "tempus.com"
},
"data": {
"detail": "Tempus is engaged in an escalating series of lawsuits with competitor Guardant Health, which alleges patent infringement on its core xF and xM liquid biopsy product lines. This creates significant legal costs, management distraction, and potential risk of injunctive relief or damages that could impact revenue and market position.",
"metrics": {
"dollar_context": "Unspecified monetary damages, future mandatory royalty, costs and attorneys fees"
},
"summary": "Facing multiple patent infringement lawsuits from competitor Guardant Health over core biopsy products.",
"excerpts": "On June 11, 2024, Guardant Health Inc., or Guardant, filed a complaint against us in the U.S. District Court for the District of Delaware. The complaint alleges that the Tempus xF, Tempus xF+, Tempus xM Monitor and Tempus xM MRD products use liquid biopsy technology that infringes five Guardant U.S. patents.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1717115/000119312526206356/tem-20260331.htm",
"filing_date": "2026-05-05",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Legal tech opportunity",
"signal_category": "risk",
"regions_mentioned": [
"United States"
],
"competitors_mentioned": [
"Guardant Health Inc."
],
"technologies_mentioned": [
"liquid biopsy"
]
}
}
curl https://signals.autobound.ai/v1/signals/e4d56cc8-c580-43cc-ad58-5f43af4032b5 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"tempus.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.